The government is optimistic that national tax revenue may achieve its target of NT$1.866 trillion (US$61.93 billion) this year, after tax revenue in the first quarter hit its highest level since 2000.
Tax revenue surged 7.3 percent from a year earlier to NT$334.1 billion in the first three months of the year, after last month’s revenue increased 10.6 percent year-on-year to NT$139.4 billion, the Ministry of Finance said yesterday.
Tax revenue in the first three months was 3 percent higher than a government target, the report said.
Strong revenue from consolidated income tax, which surged 8 percent from a year earlier to NT$73.9 billion in the first quarter, reached its highest level for the period since 2000, Statistics Department Deputy Director Hsu Ray-lin (許瑞琳) told a press conference.
“We remain upbeat that annual tax revenue may reach the goal set by the government,” Hsu said.
Tax revenue from securities transactions totaled NT$20.7 billion in the first three months, up 31.3 percent from a year earlier, thanks to a rebound in stock market turnover, Hsu added.
Business tax revenue reached its highest level for the period ever in the first three months, up 4.7 percent from a year ago to NT$97.6 billion, data showed.
Revenue from the land value increment tax climbed 11.6 percent to NT$27.9 billion in the first three months from a year ago, but Hsu said the annual growth would slow this year with signs of a soft landing for the housing market.
UPGRADE AND TRANSFORM: Although the cross-strait trade deal might remain, the Ministry of Economic Affairs said businesses should prepare for any disruptions Taiwan might face a decline in foreign trade with China if the cross-strait Economic Cooperation Framework Agreement (ECFA) ends this year, Minister of Economic Affairs Shen Jong-chin (沈榮津) said yesterday. The agreement, which was signed and put into effect in 2010 to reduce trade barriers across the Taiwan Strait, is expected to end this year, despite not having an exact termination date. “We have not received notification [from China] that it wishes to terminate ECFA,” Shen told reporters prior to attending a meeting at the Legislative Yuan. “Even if we are notified, the agreement would only cease after six months.” While acknowledging the
Disposable rubber gloves are indispensable in the global fight against COVID-19, but a month’s lockdown in Malaysia, where three of every five gloves are made, has upended the supply chain and threatens to hamstring hospitals worldwide. Top Glove Corp Bhd, the world’s biggest maker of medical gloves by volume, has the capacity to make 200 million gloves a day, but a supplier shutdown has left it with only two weeks’ worth of boxes to ship them in, its founder said. “We can’t get our gloves to hospitals without cartons,” executive chairman Lim Wee Chai (林偉財) said in an interview. “Hospitals need our
OVERSEAS EXPANSION: The electronics maker said that it is on track to start shipments from its plant in Vietnam in the first half of next year Electronics manufacturer Pegatron Corp (和碩), a major supplier of Apple Inc’s iPhone 11 series, yesterday reported a 73.8 percent year-on-year surge in net profit to NT$19.32 billion (US$637.5 million) for last year. While attributing the growth to an increase in factory utilization rate, as well as operational efficiency, the company said non-operating income, which nearly tripled to NT$8.56 billion, also contributed to its bottom line. Earnings per share rose to NT$7.4 last year from NT$4.25 in 2018, it said. Pegatron’s board of directors yesterday proposed to distribute a cash dividend of NT$4.5 per share, implying a payout ratio of 60.81 percent. Addressing potential risks
Kim Forest Enterprise Co Ltd (金萬林) yesterday said that it plans to apply to the US Food and Drug Administration (FDA) for emergency use authorization (EUA) for a COVID-19 testing kit that it developed this month. Given that the FDA has been issuing such authorizations to expand the pool of available testing resources in the US, it expects to obtain approval, the company said in a statement. From last month to Tuesday, the US regulator issued 16 EUAs for as many diagnostic devices, according to its Web site. “Our diagnostic kits are not rapid-screening, but they would be able to provide the results